Cohere Health Valuation, Funding & Investors

Cohere Health is valued at $750M as of May 2025.

Last Cohere Health valuation

$750M

Series C · May 2025

Last Cohere Health funding round

$90M

Series C · May 2025

Cumulative funding Cohere Health raised

$186M

across 4 funding rounds

Key investors in Cohere Health

  • Flare Capital Partners
  • Define Ventures
  • Polaris Partners
  • Deerfield
  • Longitude Capital
  • Temasek

Cohere Health Overview

About Cohere Health

Cohere Health is a Boston-based healthcare technology company offering prior authorization and utilization management software for payers and providers. The platform uses clinical intelligence to automate medical necessity reviews, reducing approval times from weeks to hours for procedures like MRIs and infusions. Cohere Health serves major health plans including CareFirst and Martin's Point Health Care, integrating with electronic health records from Epic and Cerner. Headquartered in Boston with expansion into provider networks nationwide.


Founded

2019

HQ

United StatesBoston, MA

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Valuation

$750M (May 2025)

Cohere Health Valuation

Cohere Health is currently valued at $750M, based on its Series C in May 2025.

The $90M round was led by Temasek, with participation from Polaris Partners, Flare Capital Partners, Define Ventures, Longitude Capital and Deerfield.

Cohere Health valuation by funding round

Cohere Health valuation by funding round
DateStageValuation
May 2025Series C$750M

Cohere Health Funding History

Cohere Health has raised a total of $186M across 4 funding rounds.

Cohere Health's first fundraising round was a $10M Series A in July 2020. The most recent completed round was a $90M Series C in May 2025.

Cohere Health funding rounds

Cohere Health funding rounds
DateStageInvestorsRaisedValuationDeal Summary
May 2025Series CTemasek (lead); Polaris Partners; Flare Capital Partners; Define Ventures; Longitude Capital; Deerfield$90M$750MCohere Health is a Boston-based clinical intelligence company providing AI-powered prior authorization and utilization management solutions for health plans and risk-bearing providers. Its Cohere Unify platform streamlines payer-provider collaboration, personalizes workflows, and optimizes clinical decision-making across prior authorization, payment accuracy, risk adjustment, and population health management. The company processes over 12 million authorization requests annually, serves more than 600,000 providers, and reports 93-94% provider satisfaction with up to 8x ROI for clients. On May 14, 2025, Cohere Health raised $90 million in a Series C funding round led by Temasek Holdings, with participation from Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners. This brought total funding to $200 million. Proceeds will scale the Cohere Unify platform, expand into new clinical use cases, enhance AI-driven products including agentic AI, increase sales and marketing, and support potential small acquisitions for expertise. Founded in 2019, Cohere Health has been recognized as a Top 5 LinkedIn Startup in 2023 and 2024, a three-time KLAS Points of Light awardee, on TIME’s World’s Top HealthTech Companies 2025 list, and the 2025 Inc. 5000 list. It appears in the Gartner Hype Cycle for U.S. Healthcare Payers. As of May 6, 2025, the company's valuation stood at $750 million, with total funding raised listed at $213.1 million in one source. The funding occurs amid a healthcare tech investment environment projected at around $12 billion for 2025, down from peaks but stable. Cohere Health is positioned as an emerging leader in reimagining prior authorization through clinical intelligence and AI, differentiating from legacy systems.
Feb 2024Series CDeerfield (lead); Polaris Partners; Flare Capital Partners; Define Ventures; Longitude Capital$50M-Cohere Health is a clinical intelligence platform provider specializing in AI-driven prior authorization solutions for health plans, streamlining payer-provider collaboration, reducing administrative burdens, and improving patient access to care. Its Cohere Unify platform supports over 16 million health plan members, processes 12 million prior authorization requests annually, and auto-approves 88-90% of requests via AI, working with more than 560,000-660,000 providers. In early 2024, the company closed an additional $50 million in equity funding to support strategic investments, amid rapid growth including new partnerships with health plans like Medical Mutual, Rhyme, Humana expansion, Epic integration, and MCG. Cohere Health achieved over 60% year-over-year growth in committed annual recurring revenue in 2024, secured nine major health plan partnerships including two Blue Cross Blue Shield plans, two large regional plans, and a national risk-bearing provider, and expanded delegated clinical solutions for MSK, radiology, cardiology, GI, and sleep care. This performance earned rankings on Deloitte Technology Fast 500 (No. 218) and Inc. 5000 based on 2021-2024 revenue growth, described as triple-digit. Post-2024 developments include a $90M Series C in 2025, launch of Payment Integrity Suite, acquisition of ZignaAI, and further platform expansions for real-time operations and clinical data.
Apr 2021Series BPolaris Partners (lead); Flare Capital Partners; Define Ventures; Longitude Capital; Deerfield$36M-Cohere Health is a digital health company providing a clinical intelligence platform and AI-powered solutions for health plans and providers, focusing on prior authorization, payment accuracy, and care continuum decision-making to optimize speed, cost, and quality of care. The company, founded in 2019, automates utilization management, incorporating clinical notes and claims data to reduce administrative burdens and improve ROI up to 8x with 94% provider satisfaction. It has been recognized on TIME’s World’s Top HealthTech Companies 2025 and Inc. 5000 lists. This 2021 round contributed to Cohere Health's early growth, bringing total funding to around $106 million by a subsequent $50 million Series B round mentioned in sources. The company has since raised significantly more, with a Series C of $90 million on May 14, 2025, led by Temasek and involving the same investors: Deerfield, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners, to expand AI use cases like risk adjustment and population health management. Funds from later rounds supported AI model development, sales, marketing, and potential acquisitions. Competitive context includes streamlining payer-provider collaboration amid prior authorization challenges.
Jul 2020Series ADefine Ventures (lead); Flare Capital Partners (lead); Humana Inc.$10M-Cohere Health raised $10 million in a Series A funding round on July 27, 2020, led by Flare Capital Partners with Define Ventures as an investor and partner, plus a leading national strategic partner. The platform provides clinical intelligence and AI-powered solutions to streamline prior authorizations and improve collaboration between physicians and health plans. Two months later in October 2020, the company closed an additional $10 million extension co-led by Flare Capital Partners and Define Ventures, bringing total funding to $20 million. The funds supported enhancement of the CohereNext platform for value-based care models and company growth from five to over 100 employees in 2020.

Who has invested in Cohere Health?

7 investors have backed Cohere Health across its funding rounds, including Flare Capital Partners, Define Ventures, Polaris Partners, Deerfield, Longitude Capital and Temasek.

Lead investors include Temasek, Deerfield, Polaris Partners, Define Ventures and Flare Capital Partners.


Cohere Health Investors

Investors in Cohere Health by funding rounds participated
InvestorHQRoundsRoleFirst check
Flare Capital PartnersUnited StatesBoston, MA4LeadJul 2020
Define VenturesUnited StatesSan Francisco, CA4LeadJul 2020
Polaris PartnersUnited StatesBoston, MA3LeadApr 2021
Longitude CapitalUnited StatesSan Francisco, CA3ParticipantApr 2021
DeerfieldUnited StatesNew York City, NY3LeadApr 2021

This data is available for Pro users. Sign up to see all 7 Cohere Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Cohere Health

Cohere Health has acquired 1 company to date.

Last acquisition by Cohere Health was on September 9th 2025. Cohere Health acquired ZignaAI for undisclosed valuation.


Latest Acquisitions by Cohere Health

ZignaAI
Description
ZignaAI is a Boston-based healthcare software provider using AI for price transparency and payment accuracy. The platform estimates patient out-of-pocket costs from 1,400 insurers and 7,000 hospitals, optimizing billing for providers like ambulatory surgery centers. Integrating with EHRs such as Epic and Cerner, ZignaAI reduces denials by 80% through real-time eligibility checks. Launched in 2021, it supports compliance with US No Surprises Act requirements.
HQ CountryUnited States
HQ City
-
Deal Date9 Sep 2025
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cohere Health acquisitions and their M&A valuation multiples.

Start Free Trial

Cohere Health Competitors

Cohere Health competitors include listed companies like Craneware, Waystar and Claritev, and private ones like Pearl Health, Helian Health and NexHealth.

Public and private companies comparable to Cohere Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Pearl HealthUnited StatesNew York City, NYPrivate--$733M-
CranewareUnited KingdomUnited KingdomPublicly listed$206M$59M$589M2.7x
WaystarUnited StatesUnited StatesPublicly listed$1.1B$390M$5.1B5.2x
Helian HealthChinaHangzhouPrivate--$900M-
NexHealthUnited StatesSan Francisco, CAPrivate--$1B-
ClaritevUnited StatesUnited StatesPublicly listed$965M$466M$538M5.2x

Cohere Health Public Comps

Cohere Health is still privately-owned, but its public comps include B-Soft Co., Sphere, Hangzhou Pinming Software, Phreesia, MedicalSystem Technology, HealthStream, Craneware, Weave Communications, RaySearch Labs and Shang Gong Group.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
B-Soft Co.$157M($37M)4.7x4.8x(20.0x)(20.0x)
Sphere$70M$6M14.3x6.9x156.3x103.0x
Hangzhou Pinming Software$65M$8M12.5x11.9x100.2x-
Phreesia$481M$27M1.3x1.3x23.2x5.3x
MedicalSystem Technology$45M$12M18.9x15.6x70.7x62.9x
HealthStream$304M$63M2.8x2.6x13.2x11.2x
Craneware$206M$59M2.8x2.7x9.7x8.7x
Weave Communications$239M($13M)2.3x2.1x(44.4x)35.9x

This data is available for Pro users. Sign up to see all Cohere Health competitors and their valuation data.

Start Free Trial

Common questions about Cohere Health

When was Cohere Health founded?Cohere Health was founded in 2019.
Where is Cohere Health headquartered?Cohere Health is headquartered in Boston, MA, United States.
Is Cohere Health publicly listed?No, Cohere Health is a private, VC-backed company.
What is Cohere Health's valuation?Cohere Health was last valued at $750M in its Series C in May 2025.
How much funding has Cohere Health raised?Cohere Health has raised $186M across 4 funding rounds.
What was Cohere Health's last funding round?Cohere Health's last funding round was a $90M Series C in May 2025, led by Temasek.
Who are Cohere Health's investors?Cohere Health's investors include Flare Capital Partners, Define Ventures, Polaris Partners, Longitude Capital, Deerfield, Temasek and Humana Inc..
Which companies are comparable to Cohere Health?Companies comparable to Cohere Health include Pearl Health, Craneware, Waystar, Helian Health, NexHealth and Claritev.
How many companies has Cohere Health acquired?Cohere Health has acquired 1 company, including ZignaAI.

See companies similar to Cohere Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial